AZD-4248

N/A

Report date: 2026/01/04 11:34:35
NME

Base Information

Drug NameAZD-4248
Drug Alias NameAZD4248AZD-4248
ClassificationSmall molecules
Mechanisms of ActionNicotinamide N-methyltransferase inhibitors
TargetsNicotinamide N-methyltransferase
Therapy Area/IndicationsDiabetic Nephropathies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesAstrazeneca Plc
Inactive CompaniesN/A
Active IndicationsDiabetic Nephropathies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A